Skip to content

Study on the Efficacy of Cetirizine Combined with Acupoint Application in Treating Children with Allergic Rhinitis Complicated with Adenoid Hypertrophy and Analysis of Influencing Factors

Study on the Efficacy and Influencing Factors of Cetirizine Combined with Acupoint Application in the Treatment of Pediatric Allergic Rhinitis Complicated with Adenoidal Hypertrophy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000579
Enrollment
Unknown
Registered
2026-03-18
Start date
2026-03-30
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoid hypertrophy and allergic rhinitis

Interventions

Patch application group:The first time, we applied the patches to the Taixi, Fengmen and Lung Yu acupoints. The second time, we applied them to Bai Luo, Gao Bang and Spleen Yu acupoints. The third tim
Cetirizine group:The usage method of cetirizine hydrochloride drops is as follows: Refer to the drug instructions and administer the dosage based on body weight. Take it twice a day, once in the morni
Joint Group:Combine the two sets of treatment methods mentioned above.

Sponsors

Fengdu General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 12 Years

Inclusion criteria

Inclusion criteria: (1) All cases met the diagnostic criteria for allergic rhinitis mentioned above; among them, for the group of children with allergic rhinitis combined with adenoid hypertrophy, they also need to meet the judgment criteria for adenoid hypertrophy mentioned above. (2) Age 3-12 years old; (3) Children who have not received desensitization treatment; (4) The children and their families agreed to participate in this observational study.

Exclusion criteria

Exclusion criteria: (1) Have severe deviation of the nasal septum or other diseases in the throat or trachea that may cause breathing difficulties; (2) Have major systemic diseases such as heart, brain, kidney, blood disorders or congenital diseases; (3) Have taken anti-allergic drugs such as antihistamines, leukotriene receptor antagonists or applied anti-inflammatory drugs like glucocorticoids within the past 2 weeks; (4) Have undergone adenoidectomy in the past; (5) Are in the period of upper respiratory tract infection.

Design outcomes

Primary

MeasureTime frame
Adenoid hypertrophy condition;

Secondary

MeasureTime frame
Rhinitis symptom score;life quality score;

Countries

China

Contacts

Public ContactXiang Bin

Fengdu General Hospital

xiangbin1005@outlook.com17843770042

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026